Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
International Orthopaedics
Published in: International Orthopaedics 12/2015

01-12-2015 | Review Article

Efficacy of mesenchymal stem cells injection for the management of knee osteoarthritis: a systematic review and meta-analysis

Authors: Peng Xia, Xiaoju Wang, Qiang Lin, Xueping Li

Published in: International Orthopaedics | Issue 12/2015

Login to get access

Abstract

Objective

The purpose of this study was to access the efficacy of mesenchymal stem cells (MSCs) injection in the treatment of knee osteoarthritis (OA).

Methods

Studies were identified from databases (Pubmed, Embase, Cochrane Library, Biosis Previews, ClincalTrials.gov, CBMdisc) searched to December 2014 using a battery of keywords. We included randomized controlled and controlled clinical trials of people with knee OA comparing the outcomes of pain and function for those receiving MSCs injection with those receiving no MSCs injection. Two reviewers independently selected studies, extracted relevant data and assessed study quality. Data were pooled and meta-analyses were performed.

Results

Seven randomized controlled and controlled clinical trials, studying a total of 314 participants with a diagnosis of knee OA were included. Overall, MSCs injection has no significant effect on pain [weighted mean difference (WMD) (95 % confidence interval (CI)) [−1.33(−3.08, 0.41), P = 0.13], and tends to improve self-reported physical function [standardized mean difference (SMD) (CI) = 2.35(0.92, 3.77), P = 0.001] at the last follow-up. But results from two high quality trials (94 patients) show a positive effect of MSCs injection on pain [WMD(CI) = −0.49 (−0.79, −0.19), P = 0.001]. Heterogeneity observed between studies regarding the effect of MSCs injection on pain and function was explained by the difference of follow-up time, outcome measures, control group, the source and dose of MSCs. The quality of evidence supporting these effect estimates was rated as low.

Conclusion

MSCs injection could be potentially efficacious for decreasing pain and may improve physical function in patients with knee OA. The findings of this review should be confirmed using methodologically rigorous and adequately powered clinical trials.
Appendix
Available only for authorised users
Literature
1.
Pop T, Szczygielska D, Druzbicki M (2007)Epidemiology and cost of conservative treatment of patients with degenerative joint disease of the hip and knee. Ortop Traumatol Rehabil 9:405–412PubMed
2.
Quintana JM, Arostegui I, Escobar A et al (2008)Prevalence of knee and hip osteoarthritis and the appropriateness of joint replacement in an older population. Arch Intern Med 168:1576–1584CrossRefPubMed
3.
4.
5.
ACR (2000)American College of Rheumatology Subcommittee on osteoarthritis guidelines. Recommendations for the medical management of osteoarthritis of the hip and knee. 2000 Update. Arthritis Rheum 43:1905–1915CrossRef
6.
Felson DT, Zhang Y, Anthony JM et al (1992)Weight loss reduces the risk for symptomatic knee osteoarthritis in woman. The Framingham Study. Ann Intern Med 116:535–539CrossRefPubMed
7.
Zang W, Moskowitz RW, Nuki G et al (2008)OARSI recommendations for the management of hip and knee osteoarthritis. Part II: OARSI evidence-based, expert consensus guidelines. Osteoarthritis Cartilage 16:137–162CrossRef
8.
Bellamy N, Campbell J, Robinson V et al (2006)Intraarticular corticosteroid for treatment of osteoarthritis of the knee. Cochrane Database Sys Rev 19:CD005328
9.
Hepper CT, Halvorson JJ, Duncan ST et al (2009)The efficacy and duration of intra-articularcorticosteroid injection for knee osteoarthritis: a systematic review of level I studies. J Am Acad Orthop Surg 17:638–646PubMed
10.
Alhadlaq A, Mao JJ (2004)Mesenchymal stem cells: isolation and therapeutics. Stem Cells Dev 13:436–448CrossRefPubMed
11.
Wakitani S, Okabe T, Horibe S et al (2010)Safety of autologous bone marrow-derivedmesenchymal stem cell transplantation for cartilage repair in 41 patients with 45 joints followed for up to 11 years and 5 months. J Tissue Eng Regen Med 5:146–150CrossRef
12.
Wakitani S, Nawata M, Tensho K et al (2007)Repair of articular cartilage defects in the patello-femoraljoint with autologous bone marrow mesenchymal cell transplantation: three case reports involving nine defects in five knees. J Tissue Eng Regen Med 1:74–79CrossRefPubMed
13.
Koh YG, Jo SB, Kwon OR et al (2013)Mesenchymal stem cell injections improve symptoms of knee osteoarthritis. Arthroscopy 29:748–755CrossRefPubMed
14.
Davatchi F, Abdollahi BS, Mohyeddin M et al (2011)Mesenchymal stem cell therapy for knee osteoarthritis. Preliminary report of four patients. Int J Rheum Dis 14:211–215CrossRefPubMed
15.
Jo CH, Lee YG, Shin WH et al (2014)Intra-articularinjection of mesenchymal stem cells for the treatment of osteoarthritis of the knee: a proof-of-conceptclinical trial. Stem Cells 32:1254–1266
16.
Banares R, Albillos A, Rincon D et al (2002)Endoscopic treatment versus endoscopic plus pharmacologic treatment for acute variceal bleeding: a meta-analysis. Hepatology 35:609–615CrossRefPubMed
17.
Jüni P, Reichenbach S, Dieppe P (2006)Osteoarthritis: rational approach to treating the individual. Best Pract Res Clin Rheumatol 20:721–740CrossRefPubMed
18.
19.
Centeno CJ, Freeman MD (2014)Percutaneous injection of autologous, culture-expandedmesenchymal stem cells into carpometacarpal hand joints: a case series with an untreated comparison group. Wien Med Wochenschr 164:83–87CrossRefPubMed
20.
Chen K, Man C, Zhang B et al (2013)Effect of in vitro chondrogenic differentiation of autologous mesenchymal stem cells on cartilage and subchondral cancellous bone repair in osteoarthritis of temporomandibular joint. Int J Oral Maxillofac Surg 42:240–248CrossRefPubMed
21.
Yang XH, Peng L, Liu YS et al (2013)Bone marrow mesenchymal stem cell transplantation for the treatment of temporomandibular joint osteoarthrosis. Chin J Tissue Eng Res 17:3488–3494
22.
Centeno CJ, Busse D, Kisiday J et al (2008)Increased knee cartilage volume in degenerative joint disease using percutaneously implanted, autologous mesenchymal stem cells. Pain Physician 11:343PubMed
23.
Gupta ED, Nayyer N, Chin SP et al (2010)Clinical safety and efficacy of autologous bone marrow mesenchymal stem cell injection for the treatment of severe osteoarthritis. Int J Rheum Dis 13:42CrossRef
24.
Slynarski K, Deszczynski J, Karpinski J (2006)Fresh bone marrow and periosteum transplantation for cartilage defects of the knee. Transplant Proc 38:318–319CrossRefPubMed
25.
Orozco L, Munar A, Soler R et al (2013)Treatment of knee osteoarthritis with autologous mesenchymal stem cells: a pilot study. Transplantation 95:1535–1541CrossRefPubMed
26.
Orozco L, Munar A, Soler R et al (2014)Treatment of knee osteoarthritis with autologous mesenchymal stem cells: two-yearfollow-up results. Transplantation 97:e66–e68CrossRefPubMed
27.
Varma HS, Dadarya B, Vidyarthi A (2010)The new avenues in the management of osteo-arthritisof knee–stem cells. J Indian Med Assoc 108:583–585PubMed
28.
Wong KL, Lee KBL, Tai BC et al (2013)Injectable cultured bone marrow–derived mesenchymal stem cells in varus knees with cartilage defects undergoing high tibial osteotomy: a prospective, randomized controlled clinical trial with 2 years’ follow-up. Arthroscopy: J Arthrosc Relat Surg 29:2020–2028CrossRef
29.
Koh Y, Choi Y (2012)Infrapatellar fat pad-derivedmesenchymal stem cell therapy for knee osteoarthritis. Knee 19:902–907CrossRefPubMed
30.
Koh YG, Kwon OR, Kim YS et al (2014)Comparative outcomes of open-wedgehigh tibial osteotomy with platelet-richplasma alone or in combination with mesenchymal stem cell treatment: a prospective study. Arthroscopy 30:1453–1460CrossRefPubMed
31.
32.
Gan F, Tang C, Guo D et al (2014)The treatment of mesenchymal stem cell transplantation for knee osteoarthritis: a clinical observation study. Modern Diagn Treat 3512–13 (Article in Chinese)
33.
Tan Y, Jiang M, Yu H et al (2013)Therapeutic effect of arthroscopy combined with autologous bone marrow stem cell grafting on knee osteoarthritis. J Tradit Chin Orthop Traumatol 35–38 (Article in Chinese)
34.
Gómez-Barrena E, Solá CA, Bunu CP (2014)Regulatory authorities and orthopaedic clinical trials on expanded mesenchymal stem cells. Int Orthop 38:1803–1809CrossRefPubMed
35.
Hernigou P (2015)Bone transplantation and tissue engineering, part IV. Mesenchymal stem cells: history in orthopedic surgery from Cohnheim and Goujon to the Nobel Prize of Yamanaka. Int Orthop 39:807–817CrossRefPubMed
36.
37.
Jang S-J, Kim J-D, Cha S-S(2013)Platelet-richplasma (PRP)injections as an effective treatment for early osteoarthritis. Eur J Orthop Surg Traumatol 23:573–580
38.
Halpern B, Chaudhury S, Rodeo SA et al (2013)Clinical and MRI outcomes after platelet-richplasma treatment for knee osteoarthritis. Clin J Sport Med 23:238–239CrossRefPubMed
39.
Gobbi A, Karnatzikos G, Mahajan V et al (2012)Platelet-richplasma treatment in symptomatic patients with knee osteoarthritis: preliminary results in a group of active patients. Sports Health 4:162–172
40.
Sampson S, Reed M, Silvers H et al (2010)Injection of platelet-richplasma in patients with primary and secondary knee osteoarthritis: a pilot study. Am J Phys Med Rehabil 89:961–969CrossRefPubMed
41.
Filardo G, Kon E, Buda R et al (2011)Platelet-richplasma intra-articularknee injections for the treatment of degenerative cartilage lesions and osteoarthritis. Knee Surg Sports Traumatol Arthosc 19:528–535
Metadata
Title
Efficacy of mesenchymal stem cells injection for the management of knee osteoarthritis: a systematic review and meta-analysis
Authors
Peng Xia
Xiaoju Wang
Qiang Lin
Xueping Li
Publication date
01-12-2015
Publisher
Springer Berlin Heidelberg
Published in
International Orthopaedics / Issue 12/2015
Print ISSN: 0341-2695
Electronic ISSN: 1432-5195
DOI
https://doi.org/10.1007/s00264-015-2785-8

Other articles of this Issue 12/2015

International Orthopaedics 12/2015 Go to the issue

Original Paper

Complications following conversion of a hip hemiarthroplasty to a total hip arthroplasty

Original Paper

The effect of femoral neck osteotomy on femoral component position of a primary cementless total hip arthroplasty

Original Paper

Feasibility and barriers of treating clubfeet in four countries

Letter to the Editor

Open Achilles tenotomy and posterior capsulotomy for congenital talipes equinovarus

Original Paper

Characteristics and exacerbating factors of chronic low back pain in Parkinson’s disease

Original Paper

Mechano growth factor-E regulates apoptosis and inflammatory responses in fibroblast-like synoviocytes of knee osteoarthritis